Functional Training for Stroke Rehabilitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help people regain arm and hand movement after a stroke. It combines special devices with gentle nerve stimulation (Functional Training with SepaRRo and NeuRRoFES) to assess their impact on rehabilitation. Participants will undergo this therapy several times a week for a few weeks. It targets individuals who have experienced a specific type of stroke, retaining some arm movement but without major sensory or balance issues. As an unphased trial, this study provides a unique opportunity to explore innovative rehabilitation techniques that could enhance recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for stroke rehabilitation?
Research shows that using the SepaRRo and NeuRRoFES devices for stroke recovery remains in the early stages. Specific safety information from studies is not yet available, leaving unclear reports on how well people tolerate these devices or if any side effects exist.
The trial is marked as "Not Applicable" in terms of phase, indicating that the research focuses on evaluating the devices' functionality and potential applications rather than proving safety. Consequently, sufficient safety information for these devices is not yet available.
These devices aim to aid arm and hand recovery by using tools that do not require active movement, along with a method to stimulate muscles without surgery. While this approach appears promising, prospective participants should consult the study team about possible risks. The team can provide more detailed information on what to expect.12345Why are researchers excited about this trial?
Researchers are excited about the treatments SepaRRo and NeuRRoFES for stroke rehabilitation because they offer a novel approach to recovery. Unlike traditional therapies, which often focus on passive exercises or medications, SepaRRo and NeuRRoFES use robotic intervention and Functional Electrical Stimulation (FES) to actively engage and stimulate the upper extremities. This combination aims to enhance muscle re-education and improve motor function more effectively. Additionally, these treatments can be tailored in frequency and duration, potentially leading to faster and more personalized rehabilitation outcomes.
What evidence suggests that this novel approach is effective for stroke rehabilitation?
Studies have shown that functional training can help stroke survivors enhance their physical abilities and quality of life. This training includes high-energy activities, proving more effective than traditional methods. In this trial, participants will undergo upper extremity rehabilitation using SepaRRo and NeuRRoFES, which involves simple devices and gentle electrical stimulation. Research suggests that this approach aids arm and hand recovery, showing promise in helping stroke patients regain movement and function. Overall, these findings support the potential effectiveness of this new training method in stroke rehabilitation.36789
Who Is on the Research Team?
Chandramouli Krishnan, PT, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for individuals aged 18 to 75 who have had a stroke confirmed by imaging or clinical criteria, without major sensory deficits or severe joint limitations. It's not suitable for those with pacemakers, recent fainting spells, bilateral strokes, cognitive impairments (low scores on mental exams), severe communication difficulties, unresponsive muscles due to nerve damage, pregnancy intentions, skull fractures/head injuries in the recent past, seizures despite medication, metal implants in the skull or uncontrolled diabetes/hypertension.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive upper extremity rehabilitation using SepaRRo and NeuRRoFES 2-5 times per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Functional Training with SepaRRo and NeuRRoFES
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor